依达拉奉联合阿替普酶治疗老年急性缺血性脑卒中的疗效及对患者睡眠质量、焦虑抑郁的影响

曹妍 ,  王超慧 ,  赵现 ,  薛靖 ,  王慧娟

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (5) : 608 -612.

PDF (986KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (5) : 608 -612. DOI: 10.3969/j.issn.1674-7593.2026.05.009
论著

依达拉奉联合阿替普酶治疗老年急性缺血性脑卒中的疗效及对患者睡眠质量、焦虑抑郁的影响

作者信息 +

Efficacy of edaravone combined with alteplase in elderly patients with acute ischemic stroke and its effects on sleep quality, anxiety and depression

Author information +
文章历史 +
PDF (1008K)

摘要

目的 探究依达拉奉联合阿替普酶治疗老年急性缺血性脑卒中 (AIS) 的疗效及对患者睡眠质量、焦虑抑郁的影响。方法 选取 2023 年 1 月-2025 年 1 月邯郸市中心医院收治的 120 例 AIS 老年患者作为研究对象, 按照随机数字表法分为对照组 (采用阿替普酶进行治疗, 60 例) 和试验组 (采用依达拉奉联合阿替普酶进行治疗, 60 例)。比较两组神经功能 [美国国立卫生研究院脑卒中量表 (NIHSS)]、血清炎性因子指标 [白细胞介素-6 (IL-6)、肿瘤坏死因子-α (TNF-α)]、睡眠质量 [匹兹堡睡眠质量指数量表 (PSQI)]、焦虑和抑郁程度 [汉密尔顿焦虑量表 (HAMA)、汉密尔顿抑郁量表 (HAMD)]、临床疗效以及不良反应发生情况。结果 治疗后, 试验组 NIHSS 评分低于对照组 (P<0.05), IL-6、TNF-α 水平均低于对照组 (P<0.05), PSQI 评分、HAMA 评分以及 HAMD 评分均低于对照组 (P<0.05), 试验组总有效率高于对照组 (P<0.05); 两组不良反应总发生率比较, 差异无统计学意义 (P>0.05)。结论 依达拉奉联合阿替普酶能够有效提高 AIS 老年患者的神经功能、睡眠质量, 降低焦虑、抑郁程度, 改善血清炎性因子指标, 提高临床疗效, 且不增加不良反应。

Abstract

Objective To investigate the efficacy of edaravone combined with alteplase in the treatment of elderly patients with acute ischemic stroke (AIS) and its effects on patients' sleep quality, anxiety and depression. Methods A total of 120 elderly patients with acute ischemic stroke (AIS) admitted to Handan Central Hospital from January 2023 to January 2025 were enrolled as research subjects, they were randomly divided into the reference group (treated with alteplase, 60 cases) and the experimental group (treated with edaravone combined with alteplase, 60 cases) by the random number table method. The neurological function [National Institutes of health stroke scale (NIHSS)], serum inflammatory factor indicators [Interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)], sleep quality [Pittsburgh sleep quality index (PSQI)], anxiety and depression levels [Hamilton anxiety scale (HAMA), Hamilton depression scale (HAMD)], clinical efficacy, and adverse reactions were compared between the two groups. Results After treatment, the NIHSS score in the experimental group was lower than that in the control group (P<0.05); the levels of IL-6 and TNF-α were lower than those in the control group (P<0.05); the PSQI, HAMA and HAMD scores were all lower than those in the control group (P<0.05); the total effective rate of the experimental group was higher than that of the control group (P<0.05). There was no statistically significant difference in the total incidence of adverse reactions between the two groups (P>0.05). Conclusion Edaravone combined with alteplase can effectively improve neurological function and sleep quality, relieve anxiety and depression, reduce serum levels of inflammatory factors, enhance clinical efficacy in elderly patients with AIS, without increasing adverse reactions.

关键词

急性缺血性脑卒中 / 依达拉奉 / 阿替普酶 / 睡眠质量 / 焦虑 / 抑郁

Key words

Acute ischemic stroke / Edaravone / Alteplase / Sleep quality / Anxiety / Depression

引用本文

引用格式 ▾
曹妍,王超慧,赵现,薛靖,王慧娟. 依达拉奉联合阿替普酶治疗老年急性缺血性脑卒中的疗效及对患者睡眠质量、焦虑抑郁的影响[J]. 国际老年医学杂志, 2026, 47(5): 608-612 DOI:10.3969/j.issn.1674-7593.2026.05.009

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Ho J P, Powers W J. Contemporary management of acute ischemic stroke[J]. Annu Rev Med, 2025, 76(1): 417-429.

[2]

Liu Q, Fang J, Jiang X, et al. Endovascular thrombectomy for acute ischemic stroke in elderly patients with large ischemic cores[J]. Neurol Sci, 2024, 45(2): 663-670.

[3]

Huang H, Zong W, Tong X, et al. Effect of cerebral small vessel disease burden on outcomes in patients with acute ischemic stroke receiving endovascular treatment[J]. Front Aging Neurosci, 2022, 14: 800617.

[4]

Bogenschutz K M, Fisher D S, Wright G W. Acute ischemic stroke: a guideline-based overview of evaluation and management[J]. JAAPA, 2025, 38(5): 13-20.

[5]

Savaliya R, Chavda V K, Patel B, et al. Acute ischemic stroke: research perspective vs. clinical practice[J]. Neurosurg Rev, 2024, 47(1): 612.

[6]

Li S, Gu H Q, Li H, et al. Reteplase versus alteplase for acute ischemic stroke[J]. N Engl J Med, 2024, 390(24): 2264-2273.

[7]

Yamashita T, Abe K. Update on antioxidant therapy with edaravone: expanding applications in neurodegenerative diseases[J]. Int J Mol Sci, 2024, 25(5): 2945.

[8]

况稳龙, 章宜武. 依达拉奉联合阿替普酶治疗对急性缺血性脑卒中患者血清炎症因子及氨基末端脑钠肽前体水平的影响[J]. 基层医学论坛, 2025, 29(10): 39-42.

[9]

Kuang W L, Zhang Y W. Effects of edaravone combined with alteplase on serum inflammatory factors and n-terminal pro-brain natriuretic peptide levels in patients with acute ischemic stroke[J]. Med Forum, 2025, 29(10): 39-42.

[10]

中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.

[11]

Chinese Society of Neurology, Chinese Medical Association; Cerebrovascular Disease Group, Chinese Society of Neurology, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018[J]. Chin J Neurol, 2018, 51(9): 666-682.

[12]

Kwah L K, Diong J. National institutes of health stroke scale (NIHSS)[J]. J Physiother, 2014, 60(1): 61.

[13]

刘贤臣, 唐茂芹, 胡蕾, . 匹兹堡睡眠质量指数的信度和效度研究[J]. 中华精神科杂志, 1996, 29(2): 103-107.

[14]

Liu X C, Tang M Q, Hu L, et al. Reliability and validity study of the Pittsburgh sleep quality index[J]. Chin J Psychiatry, 1996, 29(2): 103-107.

[15]

Hamilton M. A rating scale for depression[J]. J Neurol Neurosurg Psychiatry, 1960, 23(1): 56-62.

[16]

Hamilton M. The assessment of anxiety states by rating[J]. Br J Med Psychol, 1959, 32(1): 50-55.

[17]

全国第四届脑血管病学术会议 通过. 脑卒中患者临床神经功能缺损程度评分标准[J]. 中医药临床杂志, 2023, 35(10): 2068-2069.

[18]

Formulated and Adopted by the 4th National Academic Conference on Cerebrovascular Diseases. Scoring standard for clinical neurological deficit degree in patients with stroke[J]. Clin J Tradit Chin Med, 2023, 35(10): 2068-2069.

[19]

Heo J, Sohn B. Prediction of hemorrhagic transformation in acute ischemic stroke: a never-ending endeavor[J]. Eur Radiol, 2024, 34(8): 5305-5307.

[20]

Derdeyn C. Advances in thrombectomy for acute ischemic stroke[J]. JAMA Surg, 2024, 159(6): 604-605.

[21]

Ravipati S, Amjad A, Zulfiqar K, et al. Endovascular thrombectomy for acute ischemic stroke with a large infarct area: an updated systematic review and meta-analysis of randomized controlled trials[J]. J Stroke Cerebrovasc Dis, 2024, 33(8): 107818.

[22]

Chu Y W, Chen P Y, Lin S K. Correlation between immune-inflammatory markers and clinical features in patients with acute ischemic stroke[J]. Acta Neurol Taiwan, 2020, 29(4): 103-113.

[23]

Wu L, Shi P, Zhao Y, et al. Hemorheology and inflammatory marker changes in patients with acute ischemic stroke after intravenous thrombolysis with mechanical thrombectomy[J]. Pak J Med Sci, 2024, 40(3Part-Ⅱ): 342-346.

[24]

谭玉萍, 任会菊, 张晶. 丁苯酞联合丹参多酚酸盐治疗急性缺血性脑卒中的疗效和对血清 IL-6 及 TNF-α 的影响[J]. 医药论坛杂志, 2022, 43(1): 88-91.

[25]

Tan Y P, Ren H J, Zhang J. Efficacy of Butylphthalide combined with Salvianolate in the treatment of acute ischemic stroke and its effects on serum IL-6 AND TNF-α[J]. J Med Forum, 2022, 43(1): 88-91.

[26]

Zhang P, Wang L, Xue J, et al. Sleep architecture characteristics in patients with acute ischemic stroke[J]. Sci Rep, 2025, 15(1): 16996.

[27]

冷海霞, 赵文凤, 王晃, . 老年急性缺血性脑卒中后抑郁、焦虑与认知功能状况的相关研究[J]. 神经疾病与精神卫生, 2024, 24(2): 94-99.

[28]

Leng H X, Zhao W F, Wang H, et al. Correlation between depression, anxiety, and cognitive function in elderly patients with acute ischemic stroke[J]. J Neurodis Ment Health, 2024, 24(2): 94-99.

基金资助

邯郸市科学技术研究与发展计划项目(23422083230)

AI Summary AI Mindmap
PDF (986KB)

2

访问

0

被引

详细

导航
相关文章

AI思维导图

/